SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-135403
Filing Date
2016-11-18
Accepted
2016-11-18 16:47:59
Documents
58
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v452106_10q.htm 10-Q 661024
2 EXHIBIT 31.1 v452106_ex31-1.htm EX-31.1 8955
3 EXHIBIT 31.2 v452106_ex31-2.htm EX-31.2 8970
4 EXHIBIT 32.1 v452106_ex32-1.htm EX-32.1 6097
5 EXHIBIT 32.2 v452106_ex32-2.htm EX-32.2 6491
  Complete submission text file 0001144204-16-135403.txt   3273075

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nspx-20160930.xml EX-101.INS 551290
7 XBRL TAXONOMY EXTENSION SCHEMA nspx-20160930.xsd EX-101.SCH 37377
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nspx-20160930_cal.xml EX-101.CAL 22573
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nspx-20160930_def.xml EX-101.DEF 218104
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nspx-20160930_lab.xml EX-101.LAB 259586
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nspx-20160930_pre.xml EX-101.PRE 252267
Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258
Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55331 | Film No.: 162008307
SIC: 2834 Pharmaceutical Preparations